LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03177512|
Recruitment Status : Completed
First Posted : June 6, 2017
Last Update Posted : December 16, 2019
|Condition or disease||Intervention/treatment||Phase|
|HIV Sexually Transmitted Diseases Risk Reduction Pre-Exposure Prophylaxis||Behavioral: LYNX Mobile App||Not Applicable|
Using the Information-Motivation-Behavior Skills (IMB) model, we have developed LYNX, a highly interactive mobile app to promote accurate risk perception and increase HIV/STI testing and linkage to PrEP among young men who have sex with men (YMSM). Key components of the app include Sex Pro (a personalized HIV risk score), a sex diary to facilitate accurate data collection; HIV/STI testing information and reminders; access to home HIV/STI testing options; a geospatial-based locator of HIV/STI testing sites and PrEP clinics; PrEP information and videos; and online PrEP navigation.
This study is part of the iTech NIH U19, which has an overall goal to develop innovative technology-focused interventions addressing the HIV prevention and care continuum for youth.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||61 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing and Pre-exposure Prophylaxis (PrEP) for Young Men Who Have Sex With Men|
|Actual Study Start Date :||October 25, 2018|
|Actual Primary Completion Date :||November 18, 2019|
|Actual Study Completion Date :||November 18, 2019|
|Experimental: LYNX Mobile App||
Behavioral: LYNX Mobile App
Access to the LYNX mobile app which includes the Sex Pro score tool, PrEP videos, HIV/STI testing reminders and geo-location features.
No Intervention: Control
Participants in this study arm will receive local standard of care for linkage to PrEP and HIV/STI testing.
- Acceptability [ Time Frame: 6 months ]System Usability Scale: a validated 10-measure scale that assesses subjective usability of a system, or, in this case, an app.
- Feasibility [ Time Frame: 6 months ]Frequency of logins, use of LYNX app components
- Frequency of app use [ Time Frame: 6 months ]Usage data
- Duration of app use [ Time Frame: 6 months ]Usage data
- Analysis of mobile application data showing what parts were used in order to assess what app content and functionalities are most and least utilized. [ Time Frame: 6 months ]Usage data
- Number of HIV/STI home testing kits, condoms and lube requested [ Time Frame: 6 months ]Combined usage data
- Preliminary efficacy: HIV testing frequency [ Time Frame: 6 months ]Submitted evidence of HIV test results; Self-report
- Preliminary efficacy: STI testing frequency [ Time Frame: 6 months ]Submitted evidence of STI test results; Self-report
- PrEP interest and uptake as measured by self report [ Time Frame: 6 months ]Self-report of linkage to PrEP and PrEP utilization (aggregate analysis of questionnaire and phone interview)
- Sexual and drug use behaviors, as measured via questionnaire [ Time Frame: 6 months ]Self-report by questionnaire
- Utilization of health care, by self-report via questionnaires and interviews [ Time Frame: 6 months ]Self-reported questionnaire
- Information, Motivation, Behavior (IMB) model constructs for HIV/STI testing [ Time Frame: 6 months ]Summary data from from questionnaire regarding HIV/STI testing knowledge, motivations, and behavioral skills
- Information, Motivation, Behavior (IMB) model constructs for PrEP uptake [ Time Frame: 6 months ]Summary data from from questionnaire regarding PrEP knowledge, motivations, and behavioral skills
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03177512
|United States, Florida|
|University of South Florida, Department of Pediatrics|
|Tampa, Florida, United States, 33606|
|United States, Illinois|
|The CORE Center, Cook County Health and Hospitals System|
|Chicago, Illinois, United States, 60612|
|Study Chair:||Albert Liu, M.D., MPH||Bridge HIV, San Francisco Department of Public Health|
|Study Chair:||Hyman Scott, M.D., MPH||Bridge HIV, San Francisco Department of Public Health|